Chauhan P, Byrne H, Taylor E, Sheahan P
Department of Otolaryngology, Head and Neck Surgery, South Infirmary Victoria University Hospital, Cork, Ireland.
Department of Speech and Language Therapy, South Infirmary Victoria University Hospital, Cork, Ireland.
Ir J Med Sci. 2015 Dec;184(4):825-30. doi: 10.1007/s11845-014-1183-3. Epub 2014 Aug 23.
Currently, most cases of oropharyngeal squamous cell carcinoma (OPSCC) are treated by chemoradiotherapy. However, serious concerns have arisen regarding toxicity and poor functional outcomes. Recently, transoral techniques for resection of selected OPSCC have been developed.
To review the outcomes of transoral surgery for OPSCC at our institution.
Retrospective review of 12 patients with OPSCC treated with transoral resection. Data on surgical complications, oncological outcomes, and functional outcomes were analysed.
Primary sites were tonsil (9), soft palate (1), base of tongue (1), and posterior pharyngeal wall (1). There were no surgical complications. After the mean follow-up of 19 months, there were no local or regional recurrences. Two patients (one with synchronous lung cancer) died from distant metastases. No patient required gastrostomy tube or had long-term speech or swallowing impairments.
Transoral resection is an excellent option for selected patients with OPSCC, offering excellent functional and oncological outcomes.
目前,大多数口咽鳞状细胞癌(OPSCC)病例采用放化疗进行治疗。然而,人们对毒性和功能预后不佳产生了严重担忧。最近,已开发出用于切除特定OPSCC的经口技术。
回顾我院经口手术治疗OPSCC的疗效。
对12例接受经口切除治疗的OPSCC患者进行回顾性研究。分析手术并发症、肿瘤学结局和功能结局的数据。
原发部位为扁桃体(9例)、软腭(1例)、舌根(1例)和咽后壁(1例)。无手术并发症。平均随访19个月后,无局部或区域复发。2例患者(1例合并同步肺癌)死于远处转移。无患者需要胃造瘘管,也没有长期的言语或吞咽障碍。
经口切除是特定OPSCC患者的极佳选择,可提供出色的功能和肿瘤学结局。